Skip to main content
Top
Published in: Intensive Care Medicine 6/2011

01-06-2011 | Original

Long-term sedation in intensive care unit: a randomized comparison between inhaled sevoflurane and intravenous propofol or midazolam

Authors: Malcie Mesnil, Xavier Capdevila, Sophie Bringuier, Pierre-Olivier Trine, Yoan Falquet, Jonathan Charbit, Jean-Paul Roustan, Gerald Chanques, Samir Jaber

Published in: Intensive Care Medicine | Issue 6/2011

Login to get access

Abstract

Purpose

To evaluate efficacy and adverse events related to inhaled sevoflurane for long-term sedation compared with standard intravenous (IV) sedation with propofol or midazolam.

Methods

Randomized controlled trial. Sixty intensive care unit (ICU) patients expected to require more than 24 h sedation were randomly assigned to one of three groups: group S, inhaled sevoflurane; group P, IV propofol; group M, IV midazolam. All patients also received IV remifentanil for goal-directed sedation (Ramsay scale and pain score) until extubation or for a maximum of 96 h. Primary end points were wake-up times and extubation delay from termination of sedative administration. Proportion of time within Ramsay score 3–4, IV morphine consumption at 24 h post extubation, hallucination episodes after end of sedation, adverse events, inorganic fluoride plasma levels, and ambient sevoflurane concentrations were recorded.

Results

Forty-seven patients were analyzed. Wake-up time and extubation delay were significantly (P < 0.01) shorter in group S (18.6 ± 11.8 and 33.6 ± 13.1 min) than in group P (91.3 ± 35.2 and 326.11 ± 360.2 min) or M (260.2 ± 150.2 and 599.6 ± 586.6 min). Proportion of time within desired interval of sedation score was comparable between groups. Morphine consumption during the 24 h following extubation was lower in group S than in groups P and M. Four hallucination episodes were reported in group P, five in group M, and none in group S (P = 0.04). No hepatic or renal adverse events were reported. Mean plasma fluoride value was 82 μmol l−1 (range 12–220 μmol l−1), and mean ambient sevoflurane concentration was 0.3 ± 0.1 ppm.

Conclusions

Long-term inhaled sevoflurane sedation seems to be a safe and effective alternative to IV propofol or midazolam. It decreases wake-up and extubation times, and post extubation morphine consumption, and increases awakening quality.
Appendix
Available only for authorised users
Literature
1.
go back to reference Payen JF, Chanques G, Mantz J, Hercule C, Auriant I, Leguillou JL, Binhas M, Genty C, Rolland C, Bosson JL (2007) Current practices in sedation and analgesia for mechanically ventilated critically ill patients: a prospective multicenter patient-based study. Anesthesiology 106:687–695; quiz 891-682 Payen JF, Chanques G, Mantz J, Hercule C, Auriant I, Leguillou JL, Binhas M, Genty C, Rolland C, Bosson JL (2007) Current practices in sedation and analgesia for mechanically ventilated critically ill patients: a prospective multicenter patient-based study. Anesthesiology 106:687–695; quiz 891-682
2.
go back to reference Payen JF, Bosson JL, Chanques G, Mantz J, Labarere J (2009) Pain assessment is associated with decreased duration of mechanical ventilation in the intensive care unit: a post Hoc analysis of the DOLOREA study. Anesthesiology 111:1308–1316PubMedCrossRef Payen JF, Bosson JL, Chanques G, Mantz J, Labarere J (2009) Pain assessment is associated with decreased duration of mechanical ventilation in the intensive care unit: a post Hoc analysis of the DOLOREA study. Anesthesiology 111:1308–1316PubMedCrossRef
3.
go back to reference Wunsch H, Kahn JM, Kramer AA, Rubenfeld GD (2009) Use of intravenous infusion sedation among mechanically ventilated patients in the United States. Crit Care Med 37:3031–3039PubMedCrossRef Wunsch H, Kahn JM, Kramer AA, Rubenfeld GD (2009) Use of intravenous infusion sedation among mechanically ventilated patients in the United States. Crit Care Med 37:3031–3039PubMedCrossRef
4.
go back to reference Kong KL, Willatts SM, Prys-Roberts C (1989) Isoflurane compared with midazolam for sedation in the intensive care unit. BMJ 298:1277–1280PubMedCrossRef Kong KL, Willatts SM, Prys-Roberts C (1989) Isoflurane compared with midazolam for sedation in the intensive care unit. BMJ 298:1277–1280PubMedCrossRef
5.
go back to reference Spencer EM, Willatts SM (1992) Isoflurane for prolonged sedation in the intensive care unit; efficacy and safety. Intensive Care Med 18:415–421PubMedCrossRef Spencer EM, Willatts SM (1992) Isoflurane for prolonged sedation in the intensive care unit; efficacy and safety. Intensive Care Med 18:415–421PubMedCrossRef
6.
go back to reference Millane TA, Bennett ED, Grounds RM (1992) Isoflurane and propofol for long-term sedation in the intensive care unit. A crossover study. Anaesthesia 47:768–774PubMedCrossRef Millane TA, Bennett ED, Grounds RM (1992) Isoflurane and propofol for long-term sedation in the intensive care unit. A crossover study. Anaesthesia 47:768–774PubMedCrossRef
7.
go back to reference Enlund M, Lambert H, Wiklund L (2002) The sevoflurane saving capacity of a new anaesthetic agent conserving device compared with a low flow circle system. Acta Anaesthesiol Scand 46:506–511PubMedCrossRef Enlund M, Lambert H, Wiklund L (2002) The sevoflurane saving capacity of a new anaesthetic agent conserving device compared with a low flow circle system. Acta Anaesthesiol Scand 46:506–511PubMedCrossRef
8.
go back to reference Sackey PV, Martling CR, Granath F, Radell PJ (2004) Prolonged isoflurane sedation of intensive care unit patients with the anesthetic conserving device. Crit Care Med 32:2241–2246PubMed Sackey PV, Martling CR, Granath F, Radell PJ (2004) Prolonged isoflurane sedation of intensive care unit patients with the anesthetic conserving device. Crit Care Med 32:2241–2246PubMed
9.
go back to reference Rohm KD, Wolf MW, Schollhorn T, Schellhaass A, Boldt J, Piper SN (2008) Short-term sevoflurane sedation using the anaesthetic conserving device after cardiothoracic surgery. Intensive Care Med 34:1683–1689PubMedCrossRef Rohm KD, Wolf MW, Schollhorn T, Schellhaass A, Boldt J, Piper SN (2008) Short-term sevoflurane sedation using the anaesthetic conserving device after cardiothoracic surgery. Intensive Care Med 34:1683–1689PubMedCrossRef
10.
go back to reference Rozendaal FW, Spronk PE, Snellen FF, Schoen A, van Zanten AR, Foudraine NA, Mulder PG, Bakker J (2009) Remifentanil-propofol analgo-sedation shortens duration of ventilation and length of ICU stay compared to a conventional regimen: a centre randomised, cross-over, open-label study in the Netherlands. Intensive Care Med 35:291–298PubMedCrossRef Rozendaal FW, Spronk PE, Snellen FF, Schoen A, van Zanten AR, Foudraine NA, Mulder PG, Bakker J (2009) Remifentanil-propofol analgo-sedation shortens duration of ventilation and length of ICU stay compared to a conventional regimen: a centre randomised, cross-over, open-label study in the Netherlands. Intensive Care Med 35:291–298PubMedCrossRef
11.
go back to reference Spies C, Macguill M, Heymann A, Ganea C, Krahne D, Assman A, Kosiek HR, Scholtz K, Wernecke KD, Martin J (2010) A prospective, randomized, double-blind, multicenter study comparing remifentanil with fentanyl in mechanically ventilated patients. Intensive Care Med Spies C, Macguill M, Heymann A, Ganea C, Krahne D, Assman A, Kosiek HR, Scholtz K, Wernecke KD, Martin J (2010) A prospective, randomized, double-blind, multicenter study comparing remifentanil with fentanyl in mechanically ventilated patients. Intensive Care Med
12.
go back to reference Komatsu R, Turan AM, Orhan-Sungur M, McGuire J, Radke OC, Apfel CC (2007) Remifentanil for general anaesthesia: a systematic review. Anaesthesia 62:1266–1280PubMedCrossRef Komatsu R, Turan AM, Orhan-Sungur M, McGuire J, Radke OC, Apfel CC (2007) Remifentanil for general anaesthesia: a systematic review. Anaesthesia 62:1266–1280PubMedCrossRef
13.
go back to reference Kress JP, Vinayak AG, Levitt J, Schweickert WD, Gehlbach BK, Zimmerman F, Pohlman AS, Hall JB (2007) Daily sedative interruption in mechanically ventilated patients at risk for coronary artery disease. Crit Care Med 35:365–371PubMedCrossRef Kress JP, Vinayak AG, Levitt J, Schweickert WD, Gehlbach BK, Zimmerman F, Pohlman AS, Hall JB (2007) Daily sedative interruption in mechanically ventilated patients at risk for coronary artery disease. Crit Care Med 35:365–371PubMedCrossRef
14.
go back to reference Saito M, Terao Y, Fukusaki M, Makita T, Shibata O, Sumikawa K (2003) Sequential use of midazolam and propofol for long-term sedation in postoperative mechanically ventilated patients. Anesth Analg 96:834–838, table of contents Saito M, Terao Y, Fukusaki M, Makita T, Shibata O, Sumikawa K (2003) Sequential use of midazolam and propofol for long-term sedation in postoperative mechanically ventilated patients. Anesth Analg 96:834–838, table of contents
15.
go back to reference Kress JP, Pohlman AS, O’Connor MF, Hall JB (2000) Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 342:1471–1477PubMedCrossRef Kress JP, Pohlman AS, O’Connor MF, Hall JB (2000) Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 342:1471–1477PubMedCrossRef
16.
go back to reference Brook AD, Ahrens TS, Schaiff R, Prentice D, Sherman G, Shannon W, Kollef MH (1999) Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med 27:2609–2615PubMedCrossRef Brook AD, Ahrens TS, Schaiff R, Prentice D, Sherman G, Shannon W, Kollef MH (1999) Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med 27:2609–2615PubMedCrossRef
17.
go back to reference Barrientos-Vega R, Mar Sanchez-Soria M, Morales-Garcia C, Robas-Gomez A, Cuena-Boy R, Ayensa-Rincon A (1997) Prolonged sedation of critically ill patients with midazolam or propofol: impact on weaning and costs. Crit Care Med 25:33–40PubMedCrossRef Barrientos-Vega R, Mar Sanchez-Soria M, Morales-Garcia C, Robas-Gomez A, Cuena-Boy R, Ayensa-Rincon A (1997) Prolonged sedation of critically ill patients with midazolam or propofol: impact on weaning and costs. Crit Care Med 25:33–40PubMedCrossRef
18.
go back to reference Carrasco G, Molina R, Costa J, Soler JM, Cabre L (1993) Propofol vs midazolam in short-, medium-, and long-term sedation of critically ill patients. A cost-benefit analysis. Chest 103:557–564PubMedCrossRef Carrasco G, Molina R, Costa J, Soler JM, Cabre L (1993) Propofol vs midazolam in short-, medium-, and long-term sedation of critically ill patients. A cost-benefit analysis. Chest 103:557–564PubMedCrossRef
19.
go back to reference Walder B, Elia N, Henzi I, Romand JR, Tramer MR (2001) A lack of evidence of superiority of propofol versus midazolam for sedation in mechanically ventilated critically ill patients: a qualitative and quantitative systematic review. Anesth Analg 92:975–983PubMedCrossRef Walder B, Elia N, Henzi I, Romand JR, Tramer MR (2001) A lack of evidence of superiority of propofol versus midazolam for sedation in mechanically ventilated critically ill patients: a qualitative and quantitative systematic review. Anesth Analg 92:975–983PubMedCrossRef
20.
go back to reference Sackey PV, Martling CR, Carlsward C, Sundin O, Radell PJ (2008) Short- and long-term follow-up of intensive care unit patients after sedation with isoflurane and midazolam–a pilot study. Crit Care Med 36:801–806PubMedCrossRef Sackey PV, Martling CR, Carlsward C, Sundin O, Radell PJ (2008) Short- and long-term follow-up of intensive care unit patients after sedation with isoflurane and midazolam–a pilot study. Crit Care Med 36:801–806PubMedCrossRef
21.
go back to reference Ely EW, Shintani A, Truman B, Speroff T, Gordon SM, Harrell FE Jr, Inouye SK, Bernard GR, Dittus RS (2004) Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 291:1753–1762PubMedCrossRef Ely EW, Shintani A, Truman B, Speroff T, Gordon SM, Harrell FE Jr, Inouye SK, Bernard GR, Dittus RS (2004) Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 291:1753–1762PubMedCrossRef
22.
go back to reference Hollmann MW, Liu HT, Hoenemann CW, Liu WH, Durieux ME (2001) Modulation of NMDA receptor function by ketamine and magnesium. Part II: interactions with volatile anesthetics. Anesth Analg 92:1182–1191PubMedCrossRef Hollmann MW, Liu HT, Hoenemann CW, Liu WH, Durieux ME (2001) Modulation of NMDA receptor function by ketamine and magnesium. Part II: interactions with volatile anesthetics. Anesth Analg 92:1182–1191PubMedCrossRef
23.
go back to reference Matute E, Lopez-Garcia JA (2003) Characterisation of sevoflurane effects on spinal somato-motor nociceptive and non-nociceptive transmission in neonatal rat spinal cord: an electrophysiological study in vitro. Neuropharmacology 44:811–816PubMedCrossRef Matute E, Lopez-Garcia JA (2003) Characterisation of sevoflurane effects on spinal somato-motor nociceptive and non-nociceptive transmission in neonatal rat spinal cord: an electrophysiological study in vitro. Neuropharmacology 44:811–816PubMedCrossRef
24.
go back to reference Richebe P, Rivalan B, Rivat C, Laulin JP, Janvier G, Maurette P, Simonnet G (2009) Effects of sevoflurane on carrageenan- and fentanyl-induced pain hypersensitivity in Sprague-Dawley rats. Can J Anaesth 56:126–135PubMedCrossRef Richebe P, Rivalan B, Rivat C, Laulin JP, Janvier G, Maurette P, Simonnet G (2009) Effects of sevoflurane on carrageenan- and fentanyl-induced pain hypersensitivity in Sprague-Dawley rats. Can J Anaesth 56:126–135PubMedCrossRef
25.
go back to reference Cousins MJ, Mazze RI, Kosek JC, Hitt BA, Love FV (1974) The etiology of methoxyflurane nephrotoxicity. J Pharmacol Exp Ther 190:530–541PubMed Cousins MJ, Mazze RI, Kosek JC, Hitt BA, Love FV (1974) The etiology of methoxyflurane nephrotoxicity. J Pharmacol Exp Ther 190:530–541PubMed
26.
go back to reference Vivien B, Di Maria S, Ouattara A, Langeron O, Coriat P, Riou B (2003) Overestimation of bispectral index in sedated intensive care unit patients revealed by administration of muscle relaxant. Anesthesiology 99:9–17PubMedCrossRef Vivien B, Di Maria S, Ouattara A, Langeron O, Coriat P, Riou B (2003) Overestimation of bispectral index in sedated intensive care unit patients revealed by administration of muscle relaxant. Anesthesiology 99:9–17PubMedCrossRef
27.
go back to reference Sackey PV (2008) Frontal EEG for intensive care unit sedation: treating numbers or patients? Crit Care 12:186PubMedCrossRef Sackey PV (2008) Frontal EEG for intensive care unit sedation: treating numbers or patients? Crit Care 12:186PubMedCrossRef
28.
go back to reference Chanques G, Sebbane M, Barbotte E, Viel E, Eledjam JJ, Jaber S (2007) A prospective study of pain at rest: incidence and characteristics of an unrecognized symptom in surgical and trauma versus medical intensive care unit patients. Anesthesiology 107:858–860PubMedCrossRef Chanques G, Sebbane M, Barbotte E, Viel E, Eledjam JJ, Jaber S (2007) A prospective study of pain at rest: incidence and characteristics of an unrecognized symptom in surgical and trauma versus medical intensive care unit patients. Anesthesiology 107:858–860PubMedCrossRef
Metadata
Title
Long-term sedation in intensive care unit: a randomized comparison between inhaled sevoflurane and intravenous propofol or midazolam
Authors
Malcie Mesnil
Xavier Capdevila
Sophie Bringuier
Pierre-Olivier Trine
Yoan Falquet
Jonathan Charbit
Jean-Paul Roustan
Gerald Chanques
Samir Jaber
Publication date
01-06-2011
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 6/2011
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-011-2187-3

Other articles of this Issue 6/2011

Intensive Care Medicine 6/2011 Go to the issue